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Abstract 
A sensor system for the acquisition of acceleration signals from different locations on the heart wall during acute tests is 
described. A commercially available miniature three-axis accelerometer is mounted on a small, circular PCB. Three coating 
layers are applied to ensure the biocompatibility of the sensor: parylene-C, medical grade epoxy and PDMS. The device, intended
for use during animal experiments, is shaped as a hemisphere with radius 2 mm. The sensor assembly is a dedicated design that 
allows insertion through the heart wall and fixation on the muscle. A dedicated data acquisition board enables to readout digital 
acceleration data and ECG signal, and to transmit it wirelessly to a remote receiver. The device was tested in-vitro for electrical 
isolation and water diffusion. Later, in-vivo performance was evaluated by acquiring acceleration signals from different sites on 
the cardiac muscle of a sheep. 
© 2015 The Authors. Published by Elsevier Ltd. 
Peer-review under responsibility of the organizing committee of EUROSENSORS 2015. 
Keywords: Endocardial, accelerometer, packaging, heart wall, contraction. 
1. Introduction 
Pacemakers’ and other implantable devices’ batteries can last up to ten years. The replacement of an implantable 
battery requires the patient to undergo major surgery that can result in infections, bleeding or other complications. 
Extensive research in the last year has targeted this problem, proposing alternative ways of powering implantable 
devices. Batteries recharged by wireless power transfer represent an alternative to battery replacement surgical 
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intervention, but the need for frequent charging may be time and resource consuming [1]. Another valid solution to 
this problem is the in-vivo harvesting of mechanical energy generated from the body. Current research focusses on 
the possibilities to recruit energy from the cardiovascular system itself. Indeed, the cardiac muscle contraction 
produces rhythmic mechanical vibrations. The energy generated by these contractions can be collected and used to 
power biomedical implants [2]. However, an efficient dimensioning and positioning of a harvesting system requires 
an insight on amplitude and frequency components of the acceleration on different locations in the heart wall. Few 
devices have been proposed to detect myocardial ischemia by measuring acceleration on the pericardium [3,4]. This 
work proposes the assembly and packaging of a transcardial accelerometer designed to retrieve acceleration signals 
from the inner heart wall. 
2. Sensor assembly and packaging 
The sensor assembly consists of a saucer-shaped head and a PMMA pusher rod. A commercially available three-
axis digital accelerometer (BMA-280 Bosch Sensortec) was mounted on a circular PCB with a diameter of 3.2 mm 
and four lead wires were soldered on the back of the board. The device was protected from aggressive body fluids 
by three successive coating layers. First, a 5 μm thick parylene-C layer was deposited by chemical vapor deposition 
providing electrical insulation to the underlying electronics. Consequently, an additional layer of medical grade 
epoxy (EPO-TEK 302-3M) was applied by hand to offer additional insulation and mechanical support to the 
soldering joints of the device. Finally, a soft hemisphere in medical grade PDMS (NUSIL MED-6015) was 
fabricated around the device by curing the polymer in a Teflon mould.  
A thin layer of PDMS was spin coated on a carrier silicon wafer and small disks were cut-out, with a thickness of 
800 μm and a diameter of 8 m. One disk was glued on the back of each device. This thin disk automatically folds 
back when the device is pushed through the heart wall and snaps open in the cardiac cavity, both providing sealing 
of the opening and preventing the sensor from sliding back.  
The lead wires were glued, using medical grade epoxy, in a PMMA U-profile acting as a mechanical pusher 
during implantation. The longitudinal groove in the Plexiglas rod is aligned to the positive y-axis of the transducer. 
This groove is used as a visual reference during surgery, guiding the physician to orient the device along the 
significant physiological directions. A PMMA fixation ring is slid over the U-profile upon implantation of the 
sensor, to prevent it from migrating through the heart wall. Fig.1 presents schematic views of the packaging and the 
sensor assembly. 
Fig. 1. Top view (left), transversal section (center) and schematic 3D view (right) of the sensor. The different packaging layers are illustrated. 
3. Readout circuitry 
A dedicated data acquisition board was developed to retrieve the digital data from the sensor, and to log  it on a 
computer during animal tests. A wireless link between the sensor readout board and a remote receiver is foreseen to 
reduce the number of wires during surgery in order to improve the freedom of movement for the medical staff. Up to 
four accelerometers can be connected to a 3.0 V battery-powered board. A microcontroller (Texas Instruments 
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CC430F5137) reads out all sensors over an I2C bus and transmits the data over a bi-directional RF link functioning 
at 2.4 GHz (Nordic nRF24L01+). A biopotential analog front-end module (Texas Instruments ADS1292) can also 
be connected to the board. This module allows recording an ECG derivation that can be used to align the 
acceleration signals with other significant hemodynamics data acquired during in-vivo testing of the device. 
 Sample rates of up to 1 kHz can be selected, but after a preliminary analysis of the acquired signals, a sample 
rate of 250 Hz for both accelerometers and ECG was deemed sufficient to capture all relevant information. A similar 
board, powered by USB, receives the wireless data and transmits it over UART to USB interfacing chip (FTDI 
FT232R) to the MathWorks MATLAB software for data alignment and storage. The transmitter and receiver boards 
are depicted in Fig.2.  
Fig. 2. (a) Sensor readout and transmitter board; (b) Receiver board 
On the transmitter board the most power consuming component is the RF unit (33.9 mW). However, optimizing 
the microcontroller software and making use of the low-power mode of the transceiver, the overall power 
consumption of the board has been reduced to only 15 mW. 
4. Device testing and validation 
The functionality of the device was proven in-vitro, by soaking it for one week in saline solution 0.9 % at 37°C to 
mimic the body environment. More extensive in-vitro testing was performed on an analogous packaging strategy 
earlier proposed for a blood contacting pressure sensor [5]. Additionally, the implantable accelerometer was used to 
record in-vivo accelerations from the heart wall of a sheep.  
This study was approved by the KU Leuven animal ethics committee (P228/2014). The animal received humane 
care in compliance with the 'Principles of Laboratory Animal Care' formulated by the National Society for Medical 
Research and the 'Guide for the Care and Use of Laboratory Animals' prepared by the Institute of Laboratory 
Animal Resources (National Institutes of Health). Six ewes (Swifter-Charolais) between 45 and 72 kg were 
included. After sedation with intramuscular ketamine 15 mg/kg, anaesthesia was induced with isoflurane. After 
intubation, the animal was mechanically ventilated with the use of a volume-controlled respirator (Dräger, Julian). 
Anaesthesia was maintained with isoflurane (2-3%) in a gas mixture consisting of 80-100% oxygen supplemented 
with room air. The ruminant stomach was decompressed with a 12-bore orogastric tube. Anaesthesia was monitored 
by checking eyelid reflexes, and continuous monitoring throughout the study of end tidal CO2 (respiratory volume 
and frequency were adapted to keep it within ranges of 35-45 mmHg), ECG, heart rate, blood O2 saturation, 
peripheral arterial blood pressure, carotid arterial blood pressure, central venous pressure, right ventricular pressure, 
pulmonary arterial flow and pressure. The sheep was positioned in a right lateral position. After incising the left 
neck skin and superficial fascia, the pressure sensors were fixed into the left-sided carotid artery and jugular vein. 
After closing the skin in the neck, the sheep was turned to supine position, in order to perform a sternotomy. Then 
pericardium was opened and a pericardial cradle was made. Pulmonary arterial flow and pressure sensors were 
positioned, as well as a Millar catheter into the right ventricle for monitoring the right ventricular pressure. 
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 Once fully hemodynamically monitored, different purse sutures were performed on three epicardial sites: apical 
right ventricular free wall, basal right ventricular free wall, apical left ventricular free wall. Next, by means of a 
needle (Cystofix Ø 3,5 mm) a hole was pierced in the center of each purse suture. 
 Three miniaturized 3D-accelerometers were pushed through the openings in the heart wall and then immediately 
pulled back to prevent bleeding. Once the three axes of the sensors were well-aligned with the cardiac axes 
(longitudinal, circumferential, and radial), the sensors were fixed with two stitches (Prolene 5/0 RB-2). Fig.3 shows 
a sensor before and after insertion through the heart wall. 
Fig. 3. Trans-cardial accelerometer before (left) and after (right) insertion through the heart wall. 
 The acquisition of cardiac acceleration data was then started. Echocardiography records (Vivid 7, GE) were 
acquired simultaneously to each test. A window of five seconds of the data acquired from one of the sensors is 
presented in Fig.4a. A Fast Fourier Transform was computed in MATLAB to identify the main components in the 
spectrum of frequencies of the acceleration signal. The magnitude of the FFT of the acceleration along the different 
axes is plotted in Fig. 4b. 
Fig. 4. Five seconds window of the acceleration measured along the X, Y and Z axis and ECG signal in the (a) time and (b) frequency domain. 
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5. Conclusions 
A 3-axes endocardial accelerometer was fabricated, to acquire acceleration signals from the inner cardiac wall. A 
dedicated encapsulation was designed to ensure short term biocompatibility of the device and to prevent body fluids 
to damage the delicate electronic components. A dedicated data acquisition board was implemented to wirelessly 
read out the system. The in-vivo performance of the device was evaluated in-vivo by acquiring acceleration from 
different locations on the cardiac muscle of a sheep. A spectral analysis of the recorded signals, performed by means 
of FFT computation, allowed to identify the main frequency components of the acceleration signal. More extensive 
testing performed on different sites will provide a good mapping of the amplitude and frequency components of the 
acceleration along the heart wall, and allow to characterize how different medical conditions influence this pattern.  
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